NVST
Envista Holdings Corp Health Care Dental Equipment & Supplies Russell 3000
$23.51Close
$3.9BMarket cap
$18.95 – $30.2652-week range
Nov 4, 2026Next report · after the close
Highlights
Strengths
- Earnings growing EPS +111% year on year
Cautions
- Not in an uptrend 2 of 8 trend conditions
- Lagging the market RS 35 · weaker than 65% of stocks over 12 months
- Results soon Nov 4, 2026, in 3 days
- Financial distress Altman Z″ in the distress zone
Price
Filing Results Screen pick 52-week high and low Adjusted prices
Key figures
Off 12-month high
22%
1wk
down 0.4%
price change
1mo
up 0.2%
price change
12-month return
up 17%
market up 11% ·
its own up 7%
F-score
7 / 9
Strong
Altman Z
1.64
Elevated risk
P/E
81.9×
price / earnings
PEG
—
P/E / EPS growth
P/B
1.2×
price / book
Earnings yield
up 5.3%
EBIT / enterprise value
Cheaper than
77%
of the market · cheap
Revenue growth
up 8%
year on year
EPS growth
up 111%
latest quarter · -14 pts
Sales growth
up 7%
latest quarter · -7 pts
ROE
up 2%
return on equity
Free cash margin
up 8%
$230.4M FCF
D/E
0.47
long-term debt / equity
Net debt / EBITDA
0.7×
Interest cover
—EBIT / interest
Piotroski tests
- took on more long-term debt
- gross margin narrowed
- profitable on its assets
- generating cash from operations
- profitability improving
- profits backed by cash
- short-term liquidity improved
- no new shares issued
- assets working harder
Repair signals
- Revenue reaccelerating (-2% then +8%)
Trade setup
ATR%
3.0%
$0.70 a day · 2×ATR $22.10
RS
35 / 99
vs the universe
Trend
2 / 8
trend template
Relative volume
1.4×
vs 50-day average
Up/down volume
0.89
50 sessions
Implied move
—
no option chain · report Nov 4, 2026
Trend template · 2 of 8
- 200-day average rising for a month: passes
- Within 25% of the 52-week high: passes
Screen verdict
Did not qualify for any screen.
Warning signs
- Bankruptcy model reads distressed The Altman score sits inside the range historically associated with financial distress. It is used here only to exclude, never to rank, and it is a statistical band rather than a prediction about this company.
Last reported
Aug 5, 2026
Results reaction
Aug 5, 2026-2% vs market2 sessions after results
Financials
- Gross 55%
- Net 2%
- Free cash 8%
- Cash
- Long-term debt
| FY2020Dec 31, 2020 | FY2021Dec 31, 2021 | FY2022Dec 31, 2022 | FY2023Dec 31, 2023 | FY2024Dec 31, 2024 | FY2025Dec 31, 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $1.9B | $2.5B | $2.6B | $2.6B | $2.5B | $2.7B |
| Gross margin | 55% | 57% | 57% | 56% | 55% | 55% |
| Operating income | $43.5M | $306.2M | $319.2M | $31.5M | -$1.0B | $216.1M |
| Net income | $33.3M | $340.5M | $243.1M | -$100.2M | -$1.1B | $47.0M |
| Net margin | 2% | 14% | 9% | -4% | -45% | 2% |
| Earnings per share | $0.20 | $1.92 | $1.37 | -$0.60 | -$6.50 | $0.28 |
| Free cash flow | $236.2M | $306.9M | $107.0M | $217.5M | $302.7M | $230.4M |
| Free cash margin | 12% | 12% | 4% | 8% | 12% | 8% |
| Cash | $888.9M | $1.1B | $606.9M | $940.0M | $1.1B | $1.2B |
| Long-term debt | $907.7M | $883.4M | $870.7M | $1.4B | $1.3B | $1.4B |
| Shareholders' equity | $3.7B | $4.1B | $4.2B | $4.2B | $2.9B | $3.1B |
| Shares outstanding | 160m | 161.60m | 163.20m | 171.50m | 172.20m | 163.80m |
Filings
| Filed | Report | Period to | Lag |
|---|---|---|---|
| Aug 5, 2026 | Quarterly ↗ | Jul 3, 2026 | 33d |
| May 6, 2026 | Quarterly ↗ | Apr 3, 2026 | 33d |
| Feb 12, 2026 | Annual ↗ | Dec 31, 2025 | 43d |
| Oct 30, 2025 | Quarterly ↗ | Sep 26, 2025 | 34d |
| Jul 31, 2025 | Quarterly ↗ | Jun 27, 2025 | 34d |
| May 1, 2025 | Quarterly ↗ | Mar 28, 2025 | 34d |
| Feb 13, 2025 | Annual ↗ | Dec 31, 2024 | 44d |
| Oct 30, 2024 | Quarterly ↗ | Sep 27, 2024 | 33d |
| Aug 7, 2024 | Quarterly ↗ | Jun 28, 2024 | 40d |
| May 1, 2024 | Quarterly ↗ | Mar 29, 2024 | 33d |
| Feb 15, 2024 | Annual ↗ | Dec 31, 2023 | 46d |
| Nov 1, 2023 | Quarterly ↗ | Sep 29, 2023 | 33d |
Current reports
| Filed | Disclosed |
|---|---|
| Oct 27, 2026 | Regulation FD ↗ |
| Sep 17, 2026 | Regulation FD ↗ |
| Aug 19, 2026 | Director or officer change · Other events ↗ |
| Aug 5, 2026 | Results · Regulation FD ↗ |
| Jun 3, 2026 | Director or officer change ↗ |
| May 21, 2026 | Shareholder vote ↗ |
| May 6, 2026 | Results · Regulation FD ↗ |
| Feb 5, 2026 | Results · Regulation FD ↗ |
| Oct 29, 2025 | Results · Regulation FD ↗ |
| Oct 29, 2025 | Regulation FD ↗ |
| Sep 17, 2025 | Director or officer change ↗ |
| Jul 31, 2025 | Results · Regulation FD ↗ |